Endocrine Therapy of Physician's Choice

DRUG2 trials

Sponsors

Fudan University, Nanfang Hospital, Southern Medical University

Conditions

Brain MetastasesBreast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)HR+/HER2- Breast Cancer

Phase 2

Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

Not yet recruitingNCT07539753

Nanfang Hospital, Southern Medical UniversityBreast Cancer, Brain Metastases, HR+/HER2- Breast Cancer

Start: 2026-06-01End: 2029-08-01Target: 46Updated: 2026-04-30

Phase 3

De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial

Not yet recruitingNCT07153757

Fudan UniversityBreast Cancer Early Stage Breast Cancer (Stage 1-3)

Start: 2025-09-01End: 2033-09-01Target: 2934Updated: 2025-09-04